PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
58.91%
Revenue growth exceeding 1.5x Insurance - Life median of 2.29%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
58.91%
Gross profit growth exceeding 1.5x Insurance - Life median of 2.29%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-8.22%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-8.22%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-7.63%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-7.61%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-7.65%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.92%
OCF growth near Insurance - Life median of 26.74%. Charlie Munger might attribute it to typical sector or cyclical patterns.
28.92%
FCF growth exceeding 1.5x Insurance - Life median of 17.13%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
75.35%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 35.30%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
2151.55%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 39.87%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
1681.32%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 19.78%. Joel Greenblatt might see a short-term competitive advantage at play.
216.33%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 45.24% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
51.20%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 4.09%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
44.93%
3Y OCF/share growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm if cost advantage or brand strength explains near-term outperformance.
21.23%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
308.70%
5Y net income/share CAGR > 1.5x Insurance - Life median of 48.40%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
88.29%
3Y net income/share CAGR > 1.5x Insurance - Life median of 2.62%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
77.22%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 37.50% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
68.58%
5Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might see disciplined retention of earnings behind outperformance.
16.09%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.17%
AR growth of 7.17% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
1.68%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
2.79%
Positive BV/share change while Insurance - Life median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
2.35%
Debt growth of 2.35% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
14.01%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.